Getinge AB
STO:GETI B

Watchlist Manager
Getinge AB Logo
Getinge AB
STO:GETI B
Watchlist
Price: 168 SEK 1.6% Market Closed
Market Cap: 45.8B SEK
Have any thoughts about
Getinge AB?
Write Note

Getinge AB
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Getinge AB
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Getinge AB
STO:GETI B
Long-Term Investments
kr61m
CAGR 3-Years
212%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Long-Term Investments
kr34m
CAGR 3-Years
-60%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Long-Term Investments
kr7.3m
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Long-Term Investments
kr3m
CAGR 3-Years
-48%
CAGR 5-Years
-3%
CAGR 10-Years
41%
Arjo AB (publ)
STO:ARJO B
Long-Term Investments
kr139m
CAGR 3-Years
5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Getinge AB
Glance View

Market Cap
45.8B SEK
Industry
Health Care

Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 10,729 full-time employees. The firm provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.

GETI B Intrinsic Value
266.84 SEK
Undervaluation 37%
Intrinsic Value
Price

See Also

What is Getinge AB's Long-Term Investments?
Long-Term Investments
61m SEK

Based on the financial report for Dec 31, 2023, Getinge AB's Long-Term Investments amounts to 61m SEK.

What is Getinge AB's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
212%

The average annual Long-Term Investments growth rates for Getinge AB have been 212% over the past three years .

Back to Top